List of Evamist drug patents

Evamist is owned by Padagis Us.

Evamist contains Estradiol.

Evamist has a total of 1 drug patent out of which 1 drug patent has expired.

Expired drug patents of Evamist are:

  • US6978945

Evamist was authorised for market use on 27 July, 2007.

Evamist is available in spray;transdermal dosage forms.

The generics of Evamist are possible to be released after 31 July, 2022.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6978945 PADAGIS US Dispensing device
Jul, 2022

(6 months ago)

Drugs and Companies using ESTRADIOL ingredient

Market Authorisation Date: 27 July, 2007

Treatment: NA

Dosage: SPRAY;TRANSDERMAL

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic